This inventor holds 1 USPTO granted patent. Top assignee: Creagene Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Hye Rhan Jung: Innovator in Poliovirus Research
Introduction
Hye Rhan Jung is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His innovative work focuses on creating effective solutions for infectious diseases.
Latest Patents
Hye Rhan Jung holds a patent for a replication-competent recombinant Sabin type 1 strain of poliovirus. This patent describes a vector that contains a sequence coding for a multiple cloning site and a 3C-protease cleavage site. This vector simplifies the introduction of various vaccine genes from infectious viruses into the Sabin 1 poliovirus. It also facilitates the production of chimeric Sabin 1 polioviruses, which are anticipated to serve as powerful oral mucosal vaccines against several infectious viral diseases. He has 1 patent to his name.
Career Highlights
Hye Rhan Jung is currently associated with Creagene Inc., where he continues to advance his research in vaccine development. His work is pivotal in addressing public health challenges posed by viral infections.
Collaborations
He collaborates with Yong Soo Bae, contributing to the innovative research environment at Creagene Inc. Their partnership enhances the potential for groundbreaking discoveries in the field of virology.
Conclusion
Hye Rhan Jung's contributions to poliovirus research and vaccine development highlight his role as an influential inventor in the scientific community. His innovative approaches are expected to have a lasting impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile